Wee1 Inhibitor AZD1775 Combined with Cisplatin Potentiates Anticancer Activity against Gastric Cancer by Increasing DNA Damage and Cell Apoptosis

Dongshao Chen(Sun Yat-sen University), Xiaotian Zhang(Peking University)

BioMed Research International

June 7, 2018

10.1155/2018/5813292

Cited by 31

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties

|Signal Transduction and Targeted Therapy|2023|69

Association of fatty acids and lipids metabolism in placenta with early spontaneous pregnancy loss in Chinese women

|Food & Function|2018|17

<p>Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models</p>

|Cancer Management and Research|2019|16